Adipose-Derived Mesenchymal Stem Cells: Current Uses and Future Perspectives for Vascular Applications

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 3107

Special Issue Editor


E-Mail Website
Guest Editor
Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
Interests: adipose stromal cells; perivascular cells; endothelial cell biology; vasculogenesis; angiogenesis

Special Issue Information

Dear Colleagues,

Adipose-derived mesenchymal stem cells (AdMSCs), also known as adipose stromal cells, are among the most attractive cell types for cellular therapy. These cells are easily obtained from the patients and can be isolated and expanded in numbers sufficient for clinical applications. Pre-clinical studies and clinical trials revealed that systemic infusion of AdMSCs produces therapeutic effects in multiple pathologies. The primary mechanism of AdMSC therapeutic effects is attributed to their immunomodulatory activity. At the same time, analysis of the AdMSC niche in adipose tissue revealed that these cells are localized either peri-endothelial or in the adventitia media. AdMSCs strongly support endothelial cell proliferation and tubulogenesis in vitro and functional vessel formation in vivo, and these effects were due to AdMSC paracrine and juxtacrine activity. Vascularization of ischemic tissues, after ischemic insult or 2nd/3rd degree burns, and tissue engineered constructs are important areas of vascular medicine and biotechnology that have not yet been well addressed. Limited sources of endothelial and mural cells inhibit the progress in these areas. With the discovery of AdMSCs as a source of mural cells, there is a big opportunity to advance this field. This Topic aims to highlight the latest advances in AdMSCs used to study the principles of vasculogenesis and angiogenesis, to fabricate organs on the chip, and for tissue vascularization where AdMSCs engaged in vessel formation and stabilization. Studies comparing the vasculo-/angiogenic characteristics of AdMSCs with MSCs from other sources, as well as with mature mural cells (pericytes and smooth muscle cells) and fibroblasts are encouraged. Studies addressing the effects of chronic conditions (smoking, alcohol abuse, diabetes, obesity, metabolic syndrome, and systemic inflammation) on AdMSC angiogenic activities are welcome. We invite you to contribute original research papers, short communications, and mini-reviews.

Dr. Dmitry O. Traktuev
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipose stem/stromal cells
  • endothelial–MSC interaction
  • vasculogenesis
  • angiogenesis
  • blood perfusion
  • smooth muscle cell
  • organ-on-a-chip
  • pericyte

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 2630 KiB  
Review
Aging and Metabolic Reprogramming of Adipose-Derived Stem Cells Affect Molecular Mechanisms Related to Cardiovascular Diseases
by Paul Holvoet
Cells 2023, 12(24), 2785; https://doi.org/10.3390/cells12242785 - 7 Dec 2023
Cited by 4 | Viewed by 2852
Abstract
We performed a systematic search of the PubMed database for English-language articles related to the function of adipose-derived stem cells in the pathogenesis of cardiovascular diseases. In preclinical models, adipose-derived stem cells protected arteries and the heart from oxidative stress and inflammation and [...] Read more.
We performed a systematic search of the PubMed database for English-language articles related to the function of adipose-derived stem cells in the pathogenesis of cardiovascular diseases. In preclinical models, adipose-derived stem cells protected arteries and the heart from oxidative stress and inflammation and preserved angiogenesis. However, clinical trials did not reiterate successful treatments with these cells in preclinical models. The low success in patients may be due to aging and metabolic reprogramming associated with the loss of proliferation capacity and increased senescence of stem cells, loss of mitochondrial function, increased oxidative stress and inflammation, and adipogenesis with increased lipid deposition associated with the low potential to induce endothelial cell function and angiogenesis, cardiomyocyte survival, and restore heart function. Then, we identify noncoding RNAs that may be mechanistically related to these dysfunctions of human adipose-derived stem cells. In particular, a decrease in let-7, miR-17-92, miR-21, miR-145, and miR-221 led to the loss of their function with obesity, type 2 diabetes, oxidative stress, and inflammation. An increase in miR-34a, miR-486-5p, and mir-24-3p contributed to the loss of function, with a noteworthy increase in miR-34a with age. In contrast, miR-146a and miR-210 may protect stem cells. However, a systematic analysis of other noncoding RNAs in human adipose-derived stem cells is warranted. Overall, this review gives insight into modes to improve the functionality of human adipose-derived stem cells. Full article
Show Figures

Graphical abstract

Back to TopTop